000 01157 a2200313 4500
005 20250512035918.0
264 0 _c19890526
008 198905s 0 0 eng d
022 _a0012-6578
024 7 _a10.1177/106002808802201214
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDasta, J F
245 0 0 _aPharmacoeconomic impact of critically ill surgical patients.
_h[electronic resource]
260 _bDrug intelligence & clinical pharmacy
_cDec 1988
300 _a994-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCritical Care
_xeconomics
650 0 4 _aDiagnosis-Related Groups
650 0 4 _aDrug Therapy
_xeconomics
650 0 4 _aDrug Utilization
650 0 4 _aIntensive Care Units
_xeconomics
650 0 4 _aLength of Stay
650 0 4 _aPatients
650 0 4 _aPharmacy Service, Hospital
_xeconomics
650 0 4 _aSurgical Procedures, Operative
_xeconomics
700 1 _aArmstrong, D K
773 0 _tDrug intelligence & clinical pharmacy
_gvol. 22
_gno. 12
_gp. 994-8
856 4 0 _uhttps://doi.org/10.1177/106002808802201214
_zAvailable from publisher's website
999 _c3155369
_d3155369